| Savannah Jeane Lyons, SPT | |
|
35249 Kenai Spur Hwy Ste C, Soldotna, AK 99669-7673 | |
| (907) 420-0836 | |
| (907) 420-0837 |
| Full Name | Savannah Jeane Lyons |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 2 Years |
| Location | 35249 Kenai Spur Hwy Ste C, Soldotna, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134852007 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 192665 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Revolution Sport And Spine Therapy Llc | 6507146412 | 14 |
News Archive
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
House and Senate races heat up in Colorado, Nevada and Washington state, but health policy issues are touching a number of other contests, too, including governors' races, state ballot initiatives and elections for state representatives.
Onconova Therapeutics, Inc., a development-stage pharmaceutical company focused on discovering and developing novel small molecule drug products to treat cancer, today announced that tolerability and favorable anti-tumor activity data from a Phase 1 trial evaluating oral rigosertib, a dual pathway inhibitor, in patients with advanced solid tumors including refractory metastatic head and neck cancer were presented today at the American Association for Cancer Research Annual Meeting.
A new cross-disciplinary center will develop brain-machine interface technologies. One of the goals is to develop the next generation of technology to monitor, diagnose, and treat brain diseases while at the same time developing brand new brain-inspired AI hardware.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
› Verified 5 days ago
| Provider Name | Revolution Sport & Spine Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1598215170 PECOS PAC ID: 6507146412 Enrollment ID: O20161212001847 |
News Archive
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
House and Senate races heat up in Colorado, Nevada and Washington state, but health policy issues are touching a number of other contests, too, including governors' races, state ballot initiatives and elections for state representatives.
Onconova Therapeutics, Inc., a development-stage pharmaceutical company focused on discovering and developing novel small molecule drug products to treat cancer, today announced that tolerability and favorable anti-tumor activity data from a Phase 1 trial evaluating oral rigosertib, a dual pathway inhibitor, in patients with advanced solid tumors including refractory metastatic head and neck cancer were presented today at the American Association for Cancer Research Annual Meeting.
A new cross-disciplinary center will develop brain-machine interface technologies. One of the goals is to develop the next generation of technology to monitor, diagnose, and treat brain diseases while at the same time developing brand new brain-inspired AI hardware.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Savannah Jeane Lyons, SPT 47401 Damon Ave Unit D, Soldotna, AK 99669-9281 Ph: (816) 721-2578 | Savannah Jeane Lyons, SPT 35249 Kenai Spur Hwy Ste C, Soldotna, AK 99669-7673 Ph: (907) 420-0836 |
News Archive
Inclisiran lowers low-density lipoprotein (LDL; "bad") cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol, according to late-breaking results from the ORION 1 trial presented today in a Hot Line LBCT Session at ESC Congress.
House and Senate races heat up in Colorado, Nevada and Washington state, but health policy issues are touching a number of other contests, too, including governors' races, state ballot initiatives and elections for state representatives.
Onconova Therapeutics, Inc., a development-stage pharmaceutical company focused on discovering and developing novel small molecule drug products to treat cancer, today announced that tolerability and favorable anti-tumor activity data from a Phase 1 trial evaluating oral rigosertib, a dual pathway inhibitor, in patients with advanced solid tumors including refractory metastatic head and neck cancer were presented today at the American Association for Cancer Research Annual Meeting.
A new cross-disciplinary center will develop brain-machine interface technologies. One of the goals is to develop the next generation of technology to monitor, diagnose, and treat brain diseases while at the same time developing brand new brain-inspired AI hardware.
When bacteria wage a turf war, some of the combatants have an extra weapon. Certain strains of the bacteria E. coli produce proteins that kill competing E. coli and other like microbes, and researchers from Newcastle University in England have recently discovered something surprising about one of these lethal proteins: even after the toxic folded portion of the protein is removed, the unfolded end is still deadly.
› Verified 5 days ago
Luis Enrique Reyes Mendieta, Physical Therapist Medicare: Medicare Enrolled Practice Location: 35249 Kenai Spur Hwy, Soldotna, AK 99669 Phone: 907-781-3227 | |
Mrs. Stacy Lee Brantley, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 35551 Kenai Spur Hwy, Soldotna, AK 99669 Phone: 907-714-4534 Fax: 907-262-4783 | |
Christy Nicole Warren, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 44604 Sterling Hwy, Unit A, Soldotna, AK 99669 Phone: 907-420-0640 Fax: 907-420-0630 | |
Alaskan Physical Therapy, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 36275 Kenai Spur Hwy, Suite 5, Soldotna, AK 99669 Phone: 907-260-2679 Fax: 907-260-2676 | |
Zachary Michael Huot, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 230 E Marydale Ave, Soldotna, AK 99669 Phone: 907-262-3119 Fax: 907-262-9290 | |
Aspen Physical Therapy Pc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 221 W. Marydale Ave, Soldotna, AK 99669 Phone: 907-262-2596 |